National Research (NASDAQ:NRC) Sees Large Volume Increase

National Research Co. (NASDAQ:NRC) saw unusually-strong trading volume on Thursday . Approximately 178,489 shares changed hands during trading, an increase of 124% from the previous session’s volume of 79,638 shares.The stock last traded at $22.94 and had previously closed at $23.00.

National Research Trading Up 0.3 %

The firm has a market cap of $548.05 million, a P/E ratio of 18.51 and a beta of 0.56. The firm has a fifty day moving average of $29.28 and a 200-day moving average of $35.60. The company has a debt-to-equity ratio of 0.75, a quick ratio of 0.41 and a current ratio of 0.41.

National Research (NASDAQ:NRC) last announced its quarterly earnings data on Tuesday, May 7th. The company reported $0.27 earnings per share for the quarter. The business had revenue of $35.31 million during the quarter. National Research had a return on equity of 54.83% and a net margin of 20.60%.

National Research Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Monday, July 15th. Investors of record on Friday, June 28th will be issued a $0.12 dividend. The ex-dividend date is Friday, June 28th. This represents a $0.48 annualized dividend and a yield of 2.09%. National Research’s dividend payout ratio (DPR) is currently 38.71%.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of the company. Benjamin F. Edwards & Company Inc. grew its holdings in National Research by 860.2% during the 1st quarter. Benjamin F. Edwards & Company Inc. now owns 1,133 shares of the company’s stock worth $45,000 after acquiring an additional 1,015 shares during the period. Gladius Capital Management LP increased its stake in National Research by 59.8% in the fourth quarter. Gladius Capital Management LP now owns 1,326 shares of the company’s stock valued at $52,000 after purchasing an additional 496 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank grew its holdings in shares of National Research by 184.3% in the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 3,179 shares of the company’s stock valued at $126,000 after buying an additional 2,061 shares during the period. SG Americas Securities LLC bought a new stake in shares of National Research in the 4th quarter valued at $147,000. Finally, SYSTM Wealth Solutions LLC bought a new position in National Research during the first quarter worth about $170,000. 47.26% of the stock is currently owned by institutional investors and hedge funds.

National Research Company Profile

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty.